PsychCase360
Expert-Driven Psychiatry Case: Tardive Dyskinesia
Episode 1: Patient Case Report
Episode 2: Diagnosing Movement Disorders
Episode 3: Approved Treatments and Best Practices
Episode 4: Key Counseling Points
Episode 5: Treatment Monitoring and Outcomes
Episode 6: Case Summary
Tardive dyskinesia is a neurological movement disorder that can be difficult to identify and diagnose. This case report supports clinicians with a patient-first approach.
In this tardive dyskinesia (TD) case report, psychiatrist Craig Chepke, MD introduces his patient, James, a 50-year-old man retired from the Army who has been diagnosed with bipolar disorder. He sees Dr. Chepke for psychiatric care and recently discussed an altercation at the grocery store. His comorbidities include overweight and T2D. He’s also been experiencing abnormal movement by way of tremors.
“Don’t look for TD, you’re never going to find it,” warns Dr. Chepke. Because tardive dyskinesia can be difficult to identify, he recommends these best practices:
- Routinely monitor every patient on every antipsychotic
- Utilize structured AIMS or DISCUS, or semi-structured exams
- Ask the right questions to tease out functionality and QOL
- Once you’ve determined TD, pursue the right treatment
Through this case journey, Dr. Chepke will reveal an effective diagnostic process and best practices for treatment, including the only two FDA-approved therapies, patient care, and optimal outcomes.
Dr. Chepke advises clinicians to overcome diagnostic muscle memory. This expert-driven case report video series is an opportunity to learn new approaches for the betterment of patient outcomes.
About the Faculty
Dr. Craig Chepke is a Board-Certified psychiatrist and a Fellow of the American Psychiatric Association. He is the medical director of Excel Psychiatric Associates in Huntersville, NC and serves as an Adjunct Associate Professor of Psychiatry for Atrium Health and an Adjunct Assistant Professor of Psychiatry for the University of North Carolina School of Medicine. He has special interests in Treatment Resistant and Serious Mental Illness, movement disorders, ADHD, and sleep medicine. Dr. Chepke is a member of the Huntington Study Group and serves on the board of directors for the CURESZ foundation, a nonprofit organization dedicated to improving the lives of people living with Schizophrenia.
